The Institute of Chemical Technology (ICT) has awarded the inaugural version of 'Dr. K. Anji Reddy Memorial Fellowship for Affordable Biopharmaceuticals' to Satish Reddy, Chairman, Dr. Reddy’s Laboratories, for his immense contribution to the Indian pharmaceutical industry.

The fellowship was delivered at ICT’s 4 th edition of Biosimilar Workshop, held on February 2, 2023 in Goa. The fellowship has been envisaged to honour the life and dedication to the pharmaceutical field of Dr. K. Anji Reddy, an alumnus of ICT and founder of Dr. Reddy’s Laboratories.

The fellowship is awarded to industrialists and leaders who have made outstanding contributions in biotherapeutics and towards the growth of Indian pharmaceutical industry

As the Chairman of Dr. Reddy’s, Satish Reddy has led the organisation’s transition from a unifocused manufacturer of APIs (active pharmaceutical ingredients) to a company that moved up the value-chain with a diverse product portfolio of Finished Dosage Formulations. He oversaw the expansion and establishing of a strong footprint for Dr. Reddy’s finished dosage products in Russia, China and other emerging markets.

As an active member of major industry associations and governmental panels, he played a key role in shaping policies concerning the pharmaceutical sector that include India’s patent law, drug pricing and important amendments to the Drugs & Cosmetics Act. Keeping true to the legacy of the founder of the company, Dr. K. Anji Reddy, Satish Reddy drives the organisation's Corporate Social Responsibility initiatives. The Dr. Reddy’s Foundation, of which he is Chairman, works to help the less privileged create sustainable livelihoods through appropriate vocational education.